Journal article
Nicotine receptor partial agonists for smoking cessation.
- Abstract:
-
Can nicotine receptor partial agonists, including cytisine and varenicline, help people to stop smoking?
Expand abstract
Background
When people stop smoking they experience cravings to smoke and unpleasant mood changes. Nicotine receptor partial agonists aim to reduce these withdrawal symptoms and the pleasure people usually experience when they smoke. The most widely-available treatment in this drug type is varenicline, which is available world-wide as an aid for quitting smoking. Cytisine ...
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Version of record, pdf, 1.5MB)
-
- Publisher copy:
- 10.1002/14651858.CD006103.pub7
Authors
Bibliographic Details
- Publisher:
- Wiley Publisher's website
- Journal:
- Cochrane Database of Systematic Reviews Journal website
- Volume:
- 5
- Pages:
- CD006103
- Publication date:
- 2016-05-09
- DOI:
- EISSN:
-
1469-493X
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:350961
- UUID:
-
uuid:3a44f731-23bc-4a02-b3da-9a483868bef2
- Local pid:
- pubs:350961
- Source identifiers:
-
350961
- Deposit date:
- 2013-11-16
Terms of use
- Copyright holder:
- The Cochrane Collaboration
- Copyright date:
- 2016
- Notes:
- Copyright © 2016 The Cochrane Collaboration. Published by John Wiley and Sons, Ltd. The final version is available online from Wiley at: [10.1002/14651858.CD006103.pub7].
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record